Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record describes a completed Phase 1 study of trigriluzole with nivolumab and pembrolizumab, including its objectives, treatment plan, eligibility criteria, and outcome measures. Study documents and record history are also available.
    Difference
    68%
    Check dated 2026-11-09T13:37:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 rather than v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:25:26.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. The site revision advances from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-26T16:17:12.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T16:33:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study details page now serves a 403 Forbidden error, replacing the previous content and blocking access to the trial information and navigation on that page.
    Difference
    0.5%
    Check dated 2026-09-28T17:06:48.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Now the study page displays a 403 Forbidden error and the detailed trial content has been removed. This indicates access to the trial records is blocked and users will see an error instead of the study information.
    Difference
    21%
    Check dated 2026-09-21T22:01:46.000Z thumbnail image

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.